Ascendis Health, whose restructuring costs almost rivalled its R303m market value in its year to end-June, looks set to get a nod from shareholders on Monday on a deal from lenders that will probably result in it going private, and possibly ceasing to exist.

Shareholders must decide on a restructuring plan that will result in the group giving up its most profitable assets, leaving it with three businesses in SA: its local consumer brands business, which includes brands such as Solal; its pharmaceutical business; and parts of its medical device business...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now